Research and Markets has announced the addition of the "Europe Postherpetic Neuralgia Epidemiology and Patient Flow Analysis - 2017" report to their offering.

The report provides insights into Postherpetic Neuralgia epidemiology, Postherpetic Neuralgia diagnosed patients, and Postherpetic Neuralgia treatment rate for EU5 pharmaceutical markets.

The study measures key indicators such as prevalence of Postherpetic Neuralgia derived from epidemiological analysis, percentage of patients diagnosed with Postherpetic Neuralgia, and percentage of patients treated with a therapy.

The study helps executives estimate Postherpetic Neuralgia market potential, assess unmet need, develop drug forecasting models, and build population-based health management frameworks. The information presented in this study is used to evaluate market opportunities, effectively identify target patient population, and align marketing decisions.

The report provides estimates and forecasts of Postherpetic Neuralgia prevalence, Postherpetic Neuralgia diagnosis rate, and Postherpetic Neuralgia treatment rate for the period 2016 - 2025.

Key Features of the Report:

  • Postherpetic Neuralgia Patient Flow
  • Postherpetic Neuralgia Prevalence
  • Postherpetic Neuralgia Diagnosed Patients
  • Postherpetic Neuralgia Treated Patients

Key Topics Covered:

1. Postherpetic Neuralgia: Disease Definition

2. Postherpetic Neuralgia Patient Flow in Europe

3. Postherpetic Neuralgia Patient Flow in Germany

4. Postherpetic Neuralgia Patient Flow in France

5. Postherpetic Neuralgia Patient Flow in Spain

6. Postherpetic Neuralgia Patient Flow in Italy

7. Postherpetic Neuralgia Patient Flow in UK

For more information about this report visit http://www.researchandmarkets.com/research/xls5cx/europe